Symbol:
Pcdhb22
Name:
protocadherin beta 22
RGD ID:
1310328
Description:
Predicted to enable calcium ion binding activity. Predicted to be involved in cell adhesion. Predicted to be located in photoreceptor connecting cilium. Predicted to be active in plasma membrane. Orthologous to human PCDHB15 (protocadherin beta 15); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,6-dinitrotoluene; acrylamide.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC307486; pcdh-T5; protocadherin beta-15; protocadherin-T5
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 18 29,497,038 - 29,503,142 (+) NCBI GRCr8 mRatBN7.2 18 29,223,028 - 29,229,132 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 18 29,223,149 - 29,225,536 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 18 30,590,864 - 30,595,456 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 18 30,592,794 - 30,595,181 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 18 30,298,048 - 30,302,651 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 18 30,327,386 - 30,330,048 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 18 30,354,031 - 30,356,418 (+) NCBI Celera 18 28,918,568 - 28,921,569 (+) NCBI Celera Cytogenetic Map 18 p11 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Pcdhb22 Rat 1,2-dichloroethane decreases expression ISO Pcdhb22 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of PCDHB15 mRNA CTD PMID:28960355 Pcdhb22 Rat 1,2-dimethylhydrazine decreases expression ISO Pcdhb22 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of PCDHB15 mRNA CTD PMID:22206623 Pcdhb22 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Pcdhb22 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of PCDHB22 mRNA CTD PMID:21570461 and PMID:26377647 Pcdhb22 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PCDHB22 mRNA CTD PMID:33387578 Pcdhb22 Rat 2,4-diaminotoluene decreases expression ISO Pcdhb22 (Mus musculus) 6480464 2 and 4-diaminotoluene results in decreased expression of PCDHB22 mRNA CTD PMID:20713471 Pcdhb22 Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of PCDHB22 mRNA CTD PMID:21346803 Pcdhb22 Rat 4,4'-sulfonyldiphenol increases expression ISO Pcdhb22 (Mus musculus) 6480464 bisphenol S results in increased expression of PCDHB22 mRNA CTD PMID:30951980 Pcdhb22 Rat 4,4'-sulfonyldiphenol affects methylation ISO Pcdhb22 (Mus musculus) 6480464 bisphenol S affects the methylation of PCDHB15 gene CTD PMID:31683443 Pcdhb22 Rat acrylamide affects expression EXP 6480464 Acrylamide affects the expression of PCDHB22 mRNA CTD PMID:28959563 Pcdhb22 Rat aflatoxin B1 affects expression ISO PCDHB15 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of PCDHB15 protein CTD PMID:20106945 Pcdhb22 Rat aflatoxin B1 increases methylation ISO PCDHB15 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of PCDHB15 exon CTD PMID:30157460 Pcdhb22 Rat aflatoxin B1 decreases methylation ISO PCDHB15 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of PCDHB15 gene CTD PMID:27153756 Pcdhb22 Rat benzo[a]pyrene increases expression ISO PCDHB15 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of PCDHB15 mRNA CTD PMID:22178795 Pcdhb22 Rat benzo[a]pyrene decreases methylation ISO PCDHB15 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of PCDHB15 promoter CTD PMID:27901495 Pcdhb22 Rat benzo[a]pyrene affects methylation ISO PCDHB15 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of PCDHB15 exon CTD PMID:27901495 Pcdhb22 Rat bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PCDHB15 promoter CTD PMID:23359474 Pcdhb22 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PCDHB15 promoter CTD PMID:23359474 Pcdhb22 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PCDHB15 mRNA CTD PMID:25181051 Pcdhb22 Rat bisphenol F increases expression ISO Pcdhb22 (Mus musculus) 6480464 bisphenol F results in increased expression of PCDHB22 mRNA CTD PMID:30951980 Pcdhb22 Rat CGP 52608 multiple interactions ISO PCDHB15 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to PCDHB15 gene] CTD PMID:28238834 Pcdhb22 Rat chlorpyrifos decreases expression ISO Pcdhb22 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of PCDHB22 mRNA CTD PMID:37019170 Pcdhb22 Rat choline multiple interactions ISO Pcdhb22 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB22 mRNA CTD PMID:20938992 Pcdhb22 Rat cisplatin increases expression ISO PCDHB15 (Homo sapiens) 6480464 Cisplatin results in increased expression of PCDHB15 mRNA CTD PMID:27392435 Pcdhb22 Rat cisplatin multiple interactions ISO PCDHB15 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of PCDHB15 mRNA CTD PMID:27392435 Pcdhb22 Rat copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of PCDHB15 mRNA CTD PMID:26033743 Pcdhb22 Rat copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of PCDHB15 mRNA CTD PMID:26033743 Pcdhb22 Rat dibutyl phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PCDHB15 promoter CTD PMID:23359474 Pcdhb22 Rat dorsomorphin multiple interactions ISO PCDHB15 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB15 mRNA CTD PMID:27188386 Pcdhb22 Rat doxorubicin decreases expression ISO PCDHB15 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of PCDHB15 mRNA CTD PMID:29803840 Pcdhb22 Rat ethanol increases expression ISO Pcdhb22 (Mus musculus) 6480464 Ethanol results in increased expression of PCDHB15 mRNA CTD PMID:30319688 Pcdhb22 Rat folic acid multiple interactions ISO Pcdhb22 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB22 mRNA CTD PMID:20938992 Pcdhb22 Rat folic acid decreases expression ISO Pcdhb22 (Mus musculus) 6480464 Folic Acid results in decreased expression of PCDHB22 mRNA CTD PMID:25629700 Pcdhb22 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PCDHB22 mRNA CTD PMID:33387578 Pcdhb22 Rat L-methionine multiple interactions ISO Pcdhb22 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB22 mRNA CTD PMID:20938992 Pcdhb22 Rat lead(0) affects methylation ISO PCDHB15 (Homo sapiens) 6480464 Lead affects the methylation of PCDHB15 gene CTD PMID:31636367 Pcdhb22 Rat manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of PCDHB22 mRNA CTD PMID:28801915 Pcdhb22 Rat methotrexate affects expression ISO Pcdhb22 (Mus musculus) 6480464 Methotrexate affects the expression of PCDHB15 mRNA and Methotrexate affects the expression of PCDHB22 mRNA CTD PMID:18502557 Pcdhb22 Rat ozone multiple interactions ISO Pcdhb22 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PCDHB22 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PCDHB22 mRNA CTD PMID:34911549 Pcdhb22 Rat paracetamol affects expression ISO Pcdhb22 (Mus musculus) 6480464 Acetaminophen affects the expression of PCDHB22 mRNA CTD PMID:17562736 Pcdhb22 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PCDHB22 mRNA CTD PMID:33387578 Pcdhb22 Rat perfluorononanoic acid increases expression ISO PCDHB15 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of PCDHB15 mRNA CTD PMID:25812627 Pcdhb22 Rat perfluorooctane-1-sulfonic acid increases expression ISO PCDHB15 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of PCDHB15 mRNA CTD PMID:25812627 Pcdhb22 Rat perfluorooctanoic acid increases expression ISO PCDHB15 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of PCDHB15 mRNA CTD PMID:25812627 Pcdhb22 Rat SB 431542 multiple interactions ISO PCDHB15 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB15 mRNA CTD PMID:27188386 Pcdhb22 Rat sodium fluoride decreases expression ISO Pcdhb22 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of PCDHB22 mRNA CTD PMID:27862939 Pcdhb22 Rat sodium fluoride increases expression ISO Pcdhb22 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of PCDHB15 mRNA CTD PMID:27862939 Pcdhb22 Rat sunitinib decreases expression ISO PCDHB15 (Homo sapiens) 6480464 Sunitinib results in decreased expression of PCDHB15 mRNA CTD PMID:31533062 Pcdhb22 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of PCDHB22 mRNA CTD PMID:33387578 Pcdhb22 Rat triptonide decreases expression ISO Pcdhb22 (Mus musculus) 6480464 triptonide results in decreased expression of PCDHB15 mRNA and triptonide results in decreased expression of PCDHB22 mRNA CTD PMID:33045310 Pcdhb22 Rat trovafloxacin increases expression ISO Pcdhb22 (Mus musculus) 6480464 trovafloxacin results in increased expression of PCDHB22 mRNA CTD PMID:35537566 Pcdhb22 Rat valproic acid affects expression ISO PCDHB15 (Homo sapiens) 6480464 Valproic Acid affects the expression of PCDHB15 mRNA CTD PMID:25979313 Pcdhb22 Rat valproic acid decreases expression ISO PCDHB15 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of PCDHB15 mRNA CTD PMID:23179753 and PMID:26272509 Pcdhb22 Rat valproic acid multiple interactions ISO PCDHB15 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB15 mRNA CTD PMID:27188386
1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-diaminotoluene (ISO) 2,6-dinitrotoluene (EXP) 4,4'-sulfonyldiphenol (ISO) acrylamide (EXP) aflatoxin B1 (ISO) benzo[a]pyrene (ISO) bis(2-ethylhexyl) phthalate (EXP) bisphenol A (EXP) bisphenol F (ISO) CGP 52608 (ISO) chlorpyrifos (ISO) choline (ISO) cisplatin (ISO) copper atom (EXP) copper(0) (EXP) dibutyl phthalate (EXP) dorsomorphin (ISO) doxorubicin (ISO) ethanol (ISO) folic acid (ISO) gentamycin (EXP) L-methionine (ISO) lead(0) (ISO) manganese(II) chloride (EXP) methotrexate (ISO) ozone (ISO) paracetamol (EXP,ISO) perfluorononanoic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (ISO) SB 431542 (ISO) sodium fluoride (ISO) sunitinib (ISO) trichloroethene (EXP) triptonide (ISO) trovafloxacin (ISO) valproic acid (ISO)
Pcdhb22 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 18 29,497,038 - 29,503,142 (+) NCBI GRCr8 mRatBN7.2 18 29,223,028 - 29,229,132 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 18 29,223,149 - 29,225,536 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 18 30,590,864 - 30,595,456 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 18 30,592,794 - 30,595,181 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 18 30,298,048 - 30,302,651 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 18 30,327,386 - 30,330,048 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 18 30,354,031 - 30,356,418 (+) NCBI Celera 18 28,918,568 - 28,921,569 (+) NCBI Celera Cytogenetic Map 18 p11 NCBI
PCDHB15 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 5 141,245,395 - 141,249,365 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 5 141,245,395 - 141,249,365 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 5 140,624,963 - 140,628,933 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 5 140,605,331 - 140,607,986 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 5 140,605,330 - 140,607,983 NCBI Celera 5 136,701,975 - 136,704,630 (+) NCBI Celera Cytogenetic Map 5 q31.3 NCBI HuRef 5 135,770,205 - 135,772,860 (+) NCBI HuRef CHM1_1 5 140,058,351 - 140,061,006 (+) NCBI CHM1_1 T2T-CHM13v2.0 5 141,770,701 - 141,774,671 (+) NCBI T2T-CHM13v2.0
Pcdhb22 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 18 37,651,402 - 37,657,532 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 18 37,650,924 - 37,657,532 (+) Ensembl GRCm39 Ensembl GRCm38 18 37,518,353 - 37,521,419 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 18 37,517,871 - 37,524,479 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 18 37,678,007 - 37,681,073 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 18 37,644,327 - 37,647,393 (+) NCBI MGSCv36 mm8 Celera 18 38,869,674 - 38,872,740 (+) NCBI Celera Cytogenetic Map 18 B3 NCBI cM Map 18 19.51 NCBI
LOC100987426 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 4 136,490,132 - 136,499,118 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 5 134,629,915 - 134,638,670 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 5 136,605,233 - 136,611,147 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 5 142,721,180 - 142,724,785 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 5 142,721,472 - 142,723,835 (+) Ensembl panpan1.1 panPan2
LOC487178 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 2 36,251,313 - 36,271,637 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 2 33,302,959 - 33,323,542 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 2 36,705,659 - 36,716,774 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 2 36,705,911 - 36,710,593 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 2 33,779,722 - 33,800,301 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 2 34,590,711 - 34,611,298 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 2 35,398,365 - 35,418,957 (+) NCBI UU_Cfam_GSD_1.0
LOC100514339
PCDHB15 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 23 43,866,100 - 43,877,344 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 23 43,866,966 - 43,869,329 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666034 33,979,915 - 33,988,150 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
.
Predicted Target Of
Count of predictions: 16 Count of miRNA genes: 16 Interacting mature miRNAs: 16 Transcripts: ENSRNOT00000027133 Prediction methods: Miranda Result types: miRGate_prediction
1331733 Bp233 Blood pressure QTL 233 3.97196 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 18 24796977 79788953 Rat 1358358 Sradr6 Stress Responsive Adrenal Weight QTL 6 2.49 adrenal gland mass (VT:0010420) both adrenal glands wet weight (CMO:0000164) 18 11944299 59330563 Rat 1331735 Rf44 Renal function QTL 44 2.981 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 18 18234564 31359530 Rat 61382 Bp46 Blood pressure QTL 46 18.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 18 11941791 31393320 Rat 2301413 Bp318 Blood pressure QTL 318 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 18 26548082 46969551 Rat 1331741 Bp232 Blood pressure QTL 232 3.59112 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 18 21372893 83213037 Rat 61388 Bp2 Blood pressure QTL 2 3.23 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 18 1 35374722 Rat 6903359 Bp355 Blood pressure QTL 355 3.6 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 18 11944544 59796478 Rat 12904668 Bw188 Body weight QTL 188 0.03 body mass (VT:0001259) body weight (CMO:0000012) 18 26548082 46969551 Rat 2313082 Bss85 Bone structure and strength QTL 85 0.8 0.0001 long bone metaphysis morphology trait (VT:0000133) tibia midshaft total cross-sectional area (CMO:0001715) 18 14951337 59951337 Rat 12904669 Cm125 Cardiac mass QTL 125 0.001 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 18 26548082 46969551 Rat 1641923 Colcr8 Colorectal carcinoma resistance QTL 8 3.1 0.0014 intestine integrity trait (VT:0010554) poorly differentiated malignant colorectal tumor number (CMO:0002076) 18 22066242 52293055 Rat 12904670 Cm126 Cardiac mass QTL 126 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 18 26548082 46969551 Rat 2312568 Glom21 Glomerulus QTL 21 2 0.005 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 18 5185858 40503530 Rat 2300157 Bmd66 Bone mineral density QTL 66 13.1 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 18 28964853 73964853 Rat 12904677 Kidm72 Kidney mass QTL 72 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 18 26548082 46969551 Rat 1331766 Bp236 Blood pressure QTL 236 3.022 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 18 11944299 31359530 Rat 1358193 Emca2 Estrogen-induced mammary cancer QTL 2 1.6 mammary gland integrity trait (VT:0010552) post-insult time to mammary tumor formation (CMO:0000345) 18 18007599 63571040 Rat 12904673 Cm127 Cardiac mass QTL 127 0.005 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 18 26548082 46969551 Rat 12904675 Am19 Aortic mass QTL 19 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 18 26548082 46969551 Rat 631264 Scl22 Serum cholesterol level QTL 22 6.2 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 18 11941791 31393320 Rat 2293704 Bss35 Bone structure and strength QTL 35 4.59 0.0002 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 18 28964853 73964853 Rat 1331775 Bp235 Blood pressure QTL 235 3.201 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 18 18234564 31359530 Rat 2325839 Bp348 Blood pressure QTL 348 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 18 25570985 70570985 Rat 1600373 Mamtr6 Mammary tumor resistance QTL 6 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 18 19278901 83218561 Rat 2293708 Bss46 Bone structure and strength QTL 46 8.8 0.0001 lumbar vertebra morphology trait (VT:0010494) lumbar vertebra cortical cross-sectional area (CMO:0001690) 18 11791518 63636873 Rat 2300177 Bmd65 Bone mineral density QTL 65 19.7 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 18 28964853 73964853 Rat 9589153 Insul31 Insulin level QTL 31 7.15 0.05 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 18 1 42547119 Rat 1578667 Bss21 Bone structure and strength QTL 21 3.5 femur morphology trait (VT:0000559) femoral neck cortical cross-sectional area (CMO:0001702) 18 11791518 83218561 Rat 2312598 Bp340 Blood pressure QTL 340 0.05 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 18 1 30558703 Rat 2300180 Bmd67 Bone mineral density QTL 67 4.8 0.0001 femur mineral mass (VT:0010011) bone mineral density (CMO:0001226) 18 1 34291613 Rat 2299160 Iddm35 Insulin dependent diabetes mellitus QTL 35 2.79 blood glucose amount (VT:0000188) age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) 18 4207941 60377792 Rat 1578661 Bss20 Bone structure and strength QTL 20 3.7 femur morphology trait (VT:0000559) femoral neck cross-sectional area (CMO:0001697) 18 11791518 83218561 Rat 1331753 Bp231 Blood pressure QTL 231 3.643 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 18 11944299 52293055 Rat 2293661 Bss50 Bone structure and strength QTL 50 4.64 0.0003 lumbar vertebra size trait (VT:0010518) lumbar vertebra trabecular cross-sectional area (CMO:0001692) 18 1 34291613 Rat 61375 Bp41 Blood pressure QTL 41 2.4 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 18 11944299 41122201 Rat
RH134768
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 18 29,225,526 - 29,225,738 (+) MAPPER mRatBN7.2 Rnor_6.0 18 30,595,172 - 30,595,383 NCBI Rnor6.0 Rnor_5.0 18 30,302,367 - 30,302,578 UniSTS Rnor5.0 RGSC_v3.4 18 30,329,764 - 30,329,975 UniSTS RGSC3.4 Celera 18 28,921,285 - 28,921,496 UniSTS RH 3.4 Map 18 422.4 UniSTS Cytogenetic Map 18 p11 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
89
88
57
25
57
6
216
97
93
45
59
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000027133 ⟹ ENSRNOP00000027133
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 18 29,223,149 - 29,225,536 (+) Ensembl Rnor_6.0 Ensembl 18 30,592,794 - 30,595,181 (+) Ensembl
RefSeq Acc Id:
NM_001416815 ⟹ NP_001403744
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 18 29,497,038 - 29,503,142 (+) NCBI mRatBN7.2 18 29,223,028 - 29,229,132 (+) NCBI
Ensembl Acc Id:
ENSRNOP00000027133 ⟸ ENSRNOT00000027133
RefSeq Acc Id:
NP_001403744 ⟸ NM_001416815
- UniProtKB:
G3V8N1 (UniProtKB/TrEMBL), A6J378 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2005-12-06
Pcdhb22
protocadherin beta 22
Pcdhb22_predicted
protocadherin beta 22 (predicted)
Symbol and Name updated
1559027 APPROVED
2005-01-12
Pcdhb22_predicted
protocadherin beta 22 (predicted)
Symbol and Name status set to approved
70820 APPROVED
